Systemic and Intracranial Efficacy of Osimertinib in EGFR L747P-Mutant NSCLC: Case Report

INTRODUCTION: EGFR L747P mutations occur rarely, with limited preclinical research and case reports suggesting resistance to osimertinib. MAIN CONCERNS, IMPORTANT CLINICAL FINDINGS, PRIMARY DIAGNOSES, INTERVENTIONS, OUTCOMES: An 84-year-old white male with remote smoking history presented with bilat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerber, David E., Mayer, Melissa, Gagan, Jeffrey, von Itzstein, Mitchell S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919282/
https://www.ncbi.nlm.nih.gov/pubmed/35295963
http://dx.doi.org/10.1016/j.jtocrr.2022.100291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919282/
https://www.ncbi.nlm.nih.gov/pubmed/35295963
http://dx.doi.org/10.1016/j.jtocrr.2022.100291

Ejemplares similares